BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 21365405)

  • 1. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.
    Morgado M; Rolo S; Castelo-Branco M
    Int J Clin Pharm; 2011 Feb; 33(1):132-40. PubMed ID: 21365405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of pharmaceutical care intervention in HIV positive patients with hypertension: A randomized controlled study.
    Jackson IL; Ukwe CV
    J Clin Pharm Ther; 2021 Aug; 46(4):1083-1094. PubMed ID: 33666264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing Medication Adherence in Elderly Hypertensive Patients Through Pharmacist Home Visits.
    Moultry AM; Pounds K; Poon IO
    Consult Pharm; 2015 Dec; 30(12):710-9. PubMed ID: 26671271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist intervention in improving hypertension-related knowledge, treatment medication adherence and health-related quality of life: a non-clinical randomized controlled trial.
    Saleem F; Hassali MA; Shafie AA; Ul Haq N; Farooqui M; Aljadhay H; Ahmad FU
    Health Expect; 2015 Oct; 18(5):1270-81. PubMed ID: 23786500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).
    Stewart K; George J; Mc Namara KP; Jackson SL; Peterson GM; Bereznicki LR; Gee PR; Hughes JD; Bailey MJ; Hsueh YA; McDowell JM; Bortoletto DA; Lau R
    J Clin Pharm Ther; 2014 Oct; 39(5):527-34. PubMed ID: 24943987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal.
    Morgado MP; Rolo SA; Pereira L; Castelo-Branco M
    BMC Health Serv Res; 2010 Dec; 10():349. PubMed ID: 21192829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
    Lee JK; Grace KA; Taylor AJ
    JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-monitoring of blood pressure for improving adherence to antihypertensive medicines and blood pressure control: a randomized controlled trial.
    Hosseininasab M; Jahangard-Rafsanjani Z; Mohagheghi A; Sarayani A; Rashidian A; Javadi M; Ahmadvand A; Hadjibabaie M; Gholami K
    Am J Hypertens; 2014 Nov; 27(11):1339-45. PubMed ID: 24771706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of self-efficacy and social support on adherence to antihypertensive drugs.
    Criswell TJ; Weber CA; Xu Y; Carter BL
    Pharmacotherapy; 2010 May; 30(5):432-41. PubMed ID: 20411995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial.
    Alfian SD; Abdulah R; Denig P; van Boven JFM; Hak E
    BMJ Open; 2020 Jan; 10(1):e034507. PubMed ID: 31911526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pharmacist's intervention on disease related knowledge, medication adherence, HRQoL and control of blood pressure among hypertensive patients.
    Amer M; Rahman N; Nazir SR; Raza A; Riaz H; Sultana M; Sadeeqa S
    Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2607-2616. PubMed ID: 30587468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.
    Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D
    Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal.
    Garção JA; Cabrita J
    J Am Pharm Assoc (Wash); 2002; 42(6):858-64. PubMed ID: 12482009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key components of success in a randomized trial of blood pressure telemonitoring with medication therapy management pharmacists.
    Beran M; Asche SE; Bergdall AR; Crabtree B; Green BB; Groen SE; Klotzle KJ; Michels RD; Nyboer RA; O'Connor PJ; Pawloski PA; Rehrauer DJ; Sperl-Hillen JM; Trower NK; Margolis KL
    J Am Pharm Assoc (2003); 2018; 58(6):614-621. PubMed ID: 30077564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hospital pharmacist-delivered individualised pharmaceutical service intervention on clinical and patient-reported outcomes in patients with hypertension: a randomised controlled trial.
    Paudel N; Shrestha S; Marasine NR; Khanal P; Aryal S; Erku D; Poudel A
    Eur J Hosp Pharm; 2023 Nov; 30(6):316-321. PubMed ID: 34980596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multimodal blood pressure control intervention in 3 healthcare systems.
    Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP
    Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Team-based care for improving hypertension management among outpatients (TBC-HTA): study protocol for a pragmatic randomized controlled trial.
    Santschi V; Wuerzner G; Chiolero A; Burnand B; Schaller P; Cloutier L; Paradis G; Burnier M
    BMC Cardiovasc Disord; 2017 Jan; 17(1):39. PubMed ID: 28109266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.
    Carter BL; Doucette WR; Franciscus CL; Ardery G; Kluesner KM; Chrischilles EA
    Pharmacotherapy; 2010 Mar; 30(3):228-35. PubMed ID: 20180606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.